
|Articles|March 12, 2009
Roche closes $46.8 billion Genentech deal
Zurich, Switzerland - Roche Holding AG has sealed a deal with Genentech to buy the 44 percent of the company that it doesn't already own for $95 a share, CNNMoney.com reports.
Advertisement
Zurich, Switzerland
- Roche Holding AG has sealed a deal with Genentech to buy the 44 percent of the company that it doesn't already own for $95 a share, CNNMoney.com reports.
This agreement ends an eight-month battle, in which Genentech repeatedly rejected Roche’s offer. The price was negotiated from $93 per share to $95, which a Genentech board member says is a fair offer to shareholders, according to CNNMoney.com.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
CSU With Biochemical C1 Inhibitor Deficiency: Case Report Raises Diagnostic Questions
2
Clinicians Weigh Topical Sequencing and Escalation in Complex Atopic Dermatitis Cases
3
Oral Minoxidil's Steady-State Release Avoids Cardiotoxic Peaks
4
Common Mistakes in Managing Hair Loss and Pigmentary Disorders
5











